Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses ARO-MAPT Interim Results and TRiM CNS Delivery Platform in Investigational CNS Pipeline Transcript#Arrowhead #Pharmaceuticals #ARWR #Discusses #AROMAPT #Interim #Results #TRiM #CNS #Delivery #Platform #Investigational #CNS #Pipeline #Transcript
Real‑time stock data, professional analysis, and smart portfolio tools. One platform for all your investing needs.
